D
espite improvements in the care of pediatric patients with end-stage kidney disease, children receiving dialysis continue to have unacceptably high mortality, with an average lifespan that is 30 to 40 years shorter compared with individuals matched for age and ethnicity.
1,2 Current strategies to improve patient survival include preemptive transplantation and expedited transition from dialysis to transplantation. But what about the children who must have long-term dialysis? What is the best approach to improve long-term outcomes in this population, including the timing of dialysis initiation? If receiving maintenance dialysis even for a few months is associated with increased mortality, 2 could delaying dialysis initiation for a few months have a survival benefit for these children?
In adults, the Initiating Dialysis Early and Late (IDEAL) Study addressed this question in a landmark randomized controlled trial that investigated patient outcomes at early (estimated glomerular filtration rate [eGFR] of 10-15 mL/min/1.73 m 2 ) versus late (eGFR of 5-7 mL/min/ 1.73 m 2 ) dialysis initiation. 3 The primary findings showed no difference in all-cause mortality, hospitalizations, and cardiovascular events between early and late dialysis start, and this had a profound effect on clinical practice in the United States and around the world. Accordingly, the updated 2015 KDOQI (Kidney Disease Outcomes Quality Initiative) clinical practice guideline for hemodialysis adequacy specifically emphasizes that symptoms and signs associated with chronic kidney disease (CKD) complications, rather than a specific eGFR, should guide a decision to initiate dialysis. 4 As a result, there has been a shift in timing of initiation maintence dialysis in adults. The 2018 US Renal Data System (USRDS) Annual Data Report indicated that the mean eGFR at initiation of dialysis in 2016 was 9.7 mL/min/1.73 m 2 , down from a peak of 10.4 mL/min/1.73 m 2 in 2010. 1 In children, the indications to initiate maintenance dialysis are in many ways similar to those in adults and consist of a combination of clinical (eg, uncontrolled hypertension, edema, and inability to provide adequate nutrition) and biochemical (eg, hyperkalemia, hyperphosphatemia, and acidosis) characteristics. [5] [6] [7] But what about specific recommendations regarding eGFR and dialysis initiation? The early guidelines, based on experts' opinions for peritoneal dialysis (2001) 5 for hemodialysis. 8 The 2014 review on the optimal care of children receiving dialysis argued that "dialysis should be considered when the patient's eGFR decreases to 10-15 (United States: 9-14) mL/min/1.73m 2 , and recommended when eGFR is below the lower end of this range." 7(p129) Remarkably, although the IDEAL trial and many observational studies have investigated the effect of eGFR on mortality at the time of dialysis initiation in adults, 9 there have been no studies examining this important issue in children. In this issue of AJKD, Okuda et al 10 filled this gap. Using USRDS data collected from almost 10,000 children and adolescents who were aged 1 to 17 years old between 1995 and 2016, they conducted a retrospective cohort study to examine the association between eGFR at time of initiation of maintenance dialysis and risk for mortality.
The main findings of this pediatric study are consistent with the results of many adult studies: in adjusted models, compared to a reference eGFR of 7 to <9 mL/min/ 1.73 m 2 , hazard ratios for mortality were 0.57 (95% confidence interval [CI], 0.43-0.74) and 1.31 (95% CI, 1.05-1.65) in those with eGFRs < 5 and ≥12 mL/min/ 1.73 m 2 , respectively. These associations were significant in children and adolescents 6 years and older; no difference in mortality risk according to eGFR was seen in those younger than 6 years. Although during the last few years there has been a trend to initiate dialysis at lower eGFRs in adults, the opposite trend was seen in the current study: median eGFRs were 8.8 mL/min/1.73 m 2 in 2010 and 10.0 mL/min/1.73 m 2 in 2016. At first glance, a straightforward interpretation of these results suggests that, as in adults, clinical practice of dialysis initiation at relatively high eGFRs needs to be changed to lower eGFRs. However, the authors, to their credit, did not make these specific recommendations. They acknowledge many limitations of the observational study, including the potential for residual confounding and survivor bias. These limitations deserve particular attention because observational studies in adults that have used more robust statistical methods to address residual confounding and survivor bias (such as inverse probability weighting and instrumental variable analyses) have failed to show an association of higher eGFR at dialysis initiation with patient mortality. 11, 12 The survival benefit and mortality risk in this study were most apparent in groups at the extreme ends of the eGFR distribution, that is, patients with eGFRs < 5 or >12 mL/ min/1.73 m 2 . In contrast, no significant association of Related Article, p. 797 eGFR with patient mortality was evident in the intermediate eGFR levels of 5 to 12 mL/min/1.73 m 2 , the range at which dialysis is most commonly initiated (63% of incident patients). The 19% of patients who were able to initiate dialysis with an eGFR < 5 mL/min/1.73 m 2 may have been a healthier cohort because most patients, for various reasons, are unable to postpone dialysis initiation to this level of eGFR. Conversely, children who started dialysis at a relatively high eGFR may have had other CKDrelated comorbid conditions that necessitated earlier initiation of dialysis and conferred additional morality risk.
The trajectory of eGFR decline represents another potential source of confounding. In clinical practice, the decision to start dialysis, particularly peritoneal dialysis in children, is often made assuming a continued decline in eGFR based on recent trends. Recent data indicate that decline in residual kidney function during dialysis is strongly predictive of patient mortality. 13 It is possible that patients who started dialysis at lower eGFRs had a more indolent progression of disease and maintained residual kidney function after dialysis initiation, whereas a more precipitous decline in residual kidney function occurred in those who initiated dialysis earlier. Therefore, while the results of the current study contribute to a growing body of adult literature that indicate early initiation of dialysis is not associated with improved outcomes, it would be premature to conclude that there is a definitive benefit to deliberate postponement of dialysis initiation.
There are also some important differences between children and adults with end-stage kidney disease that need to be considered when addressing the issues of eGFR decline and dialysis initiation, in particular regarding definitive recommendations of dialysis initiation. The progression of CKD in children, in contrast to adults, can have a significant impact on physical and neurocognitive development. At the initiation of dialysis, approximately one-quarter to one-third of children have growth delay. 14 Developmental delay is more difficult to assess, but appears to be present in at least 25% of infants and young children with severe CKD. 15 A major goal of CKD care in the pediatric population is therefore to preserve, as much as possible, normal physical and neurologic maturation. In this setting, early initiation of dialysis may assist in the management of comorbid conditions that are associated with delays in growth and neurocognitive development, such as hypertension, acidosis, malnutrition, and anemia. [15] [16] [17] [18] In the analysis by Okuda et al, 10 patient mortality was the only outcome evaluated. In the absence of any definitive research that investigates the timing of dialysis initiation in children and its effect on childhood development, initiation of dialysis at higher eGFRs seems reasonable if growth and developmental delays are present.
Despite the limitations of the study, the results provide a timely addition to the pediatric literature that calls into question the practice of dialysis initiation at higher GFRs. Delayed initiation of dialysis, if this can be safely achieved, may be beneficial by postponing exposure to the psychological and physical burdens that are associated with maintenance dialysis. 19 An especially important consideration in this regard is the progression of cardiovascular disease (CVD) in children receiving maintenance dialysis. The results of Okuda et al confirmed CVD as the most common cause of mortality in children receiving dialysis, accounting for approximately one-third of all deaths. While cardiovascular risk factors and subclinical cardiac and vascular abnormalities are present in children before dialysis, CVD quickly accelerates after dialysis initiation. 20 Exposure to dialysis provides a perfect storm of risk factors leading to maladaptive cardiomyopathy, accelerated athero-and arteriosclerosis, and vascular calcification. 20, 21 Initiation of dialysis at eGFRs just a few points lower than currently recommended would likely delay it by several months, as was seen in the IDEAL trial. 3 In that study, although the mean difference in eGFRs at dialysis initiation was only 2.2 mL/min/1.73 m 2 , dialysis was postponed by 5.6 months in the late-start group. One can only speculate whether delayed dialysis initiation would have any effect on the progression of CVD in children.
Based on the results of this study, the pediatric nephrology community may need to reevaluate the current recommendation of dialysis initiation when eGFR decreases to just <10 mL/min/1.73 m 2 and adopt a practice that is more closely aligned with the most recent KDIGO (Kidney Disease: Improving Global Outcomes) recommendations. However, particular attention must be given to the growth and development of children approaching end-stage kidney disease, and dialysis should not be withheld in the presence of significant delays in these parameters despite a relatively high eGFR. Most importantly, the timing of dialysis initiation should balance the risks and benefits of the procedure while incorporating a patient-centered approach that encourages caregiver participation in the decision-making process. In this regard, Okuda et al are to be commended for this important contribution, which can assist both the provider and caregiver in achieving such a goal.
